Two, Five and Ten-Year Observed and Relative Survival Ratesa for Malignant Brain Tumors by
Age Groups, SEER 1973-1996
HISTOLOGY
|
ICDO Code(s) |
Age Group |
# Cases |
2-Year |
5-Year |
10-Year |
Glioblastoma
|
9440-9442 |
0-19 |
227 |
30.2 |
19.6 |
17.0 |
| 20-44 |
1,415 |
29.9 |
13.1 |
7.9 |
| 45-64 |
5,100 |
7.7 |
2.0 |
0.8 |
| 65+ |
4,961 |
2.1 |
0.3 |
0.2 |
| TOTAL |
11,703 |
|
Astrocytoma, NOS
|
9400 |
0-19 |
1,055 |
81.3 |
76.1 |
71.9 |
| 20-44 |
1,912 |
75.2 |
53.2 |
36.0 |
| 45-64 |
1,988 |
28.1 |
16.8 |
10.2 |
| 65+ |
1,656 |
7.6 |
4.4 |
2.4 |
| TOTAL |
6,611 |
|
Pilocytic astrocytoma
|
9421 |
0-19 |
478 |
95.0 |
90.6 |
88.6 |
| 20-44 |
156 |
88.3 |
86.6 |
79.6 |
| 45-64 |
29 |
79.1 |
70.3 |
61.9 |
| 65+ |
13 |
b |
b |
b |
| TOTAL |
676 |
|
Diffuse astrocytoma
|
9410, 9420 |
0-19 |
115 |
85.6 |
80.8 |
79.6 |
| 20-44 |
235 |
82.7 |
55.2 |
36.5 |
| 45-64 |
140 |
36.8 |
23.9 |
10.5 |
| 65+ |
87 |
16.3 |
6.8 |
6.8 |
| TOTAL |
577 |
|
Anaplastic astrocytoma
|
9401, 9411 |
0-19 |
140 |
62.7 |
53.4 |
48.7 |
| 20-44 |
666 |
72.4 |
48.2 |
32.5 |
| 45-64 |
505 |
31.6 |
14.9 |
9.6 |
| 65+ |
384 |
6.9 |
3.4 |
2.9 |
| TOTAL |
1,695 |
|
Oligodendroglioma
|
9450 |
0-19 |
128 |
84.8 |
79.6 |
73.6 |
| 20-44 |
579 |
90.0 |
78.5 |
59.0 |
| 45-64 |
352 |
71.4 |
48.1 |
27.2 |
| 65+ |
124 |
44.7 |
26.4 |
8.8 |
| TOTAL |
1,183 |
|
Anaplastic oligodendroglioma
ependymoma
|
9451, 9460 |
0-19 |
5 |
b |
b |
b |
| 20-44 |
53 |
79.4 |
51.7 |
27.8 |
| 45-64 |
47 |
51.6 |
34.8 |
29.8 |
| 65+ |
23 |
24.3 |
19.2 |
b |
| TOTAL |
128 |
|
Ependymoma/
anaplastic ependymoma
|
9391, 9393 |
0-19 |
336 |
67.9 |
48.4 |
41.4 |
| 20-44 |
300 |
88.8 |
82.5 |
74.6 |
| 45-64 |
181 |
80.8 |
67.2 |
52.9 |
| 65+ |
57 |
69.7 |
69.7 |
43.9 |
| TOTAL |
874 |
|
Glioma, malignant, NOS
|
9380 |
0-19 |
491 |
48.7 |
42.8 |
38.4 |
| 20-44 |
358 |
65.6 |
50.0 |
34.6 |
| 45-64 |
479 |
29.7 |
20.1 |
13.5 |
| 65+ |
735 |
9.7 |
4.8 |
3.8 |
| TOTAL |
2,063 |
|
Mixed glioma
|
9382 |
0-19 |
93 |
81.2 |
72.2 |
65.3 |
| 20-44 |
258 |
84.3 |
69.9 |
46.2 |
| 45-64 |
145 |
59.4 |
37.4 |
19.0 |
| 65+ |
44 |
40.9 |
19.9 |
10.9 |
| TOTAL |
540 |
|
Embryonal/
primitive/medulloblastoma
|
8963, 9443, 9470-9473, 9502-9503 |
0-19 |
766 |
68.0 |
50.9 |
42.9 |
| 20-44 |
237 |
74.0 |
54.9 |
44.1 |
| 45-64 |
35 |
65.9 |
46.5 |
30.1 |
| 65+ |
8 |
b |
b |
b |
| TOTAL |
1,046 |
|
Neuroepithelial
|
9381, 9423, 9430 |
0-19 |
60 |
76.5 |
63.7 |
61.9 |
| 20-44 |
60 |
66.9 |
53.8 |
33.0 |
| 45-64 |
60 |
30.4 |
22.0 |
11.3 |
| 65+ |
39 |
11.2 |
3.1 |
3.1 |
| TOTAL |
219 |
|
Malignant
neuronal/glial, neuronal and mixed
|
8680, 9364, 9490-9491, 9500, 9505-9506 |
0-19 |
105 |
66.8 |
52.4 |
51.0 |
| 20-44 |
30 |
69.4 |
58.2 |
48.5 |
| 45-64 |
11 |
b |
b |
b |
| 65+ |
2 |
b |
b |
b |
| TOTAL |
148 |
|
TOTAL: All Brain and CNSc
|
8000-9989 |
0-19 |
4,239 |
70.9 |
61.1 |
56.3 |
| 20-44 |
6,570 |
67.2 |
49.0 |
35.2 |
| 45-64 |
9,579 |
22.3 |
13.3 |
8.5 |
| 65+ |
8,983 |
8.1 |
4.7 |
3.0 |
| TOTAL |
29,371 |
|
a Rates are an estimate of the percentage of patients alive at two, five and ten years, respectively.
b Too few cases to estimate.
c Includes histologies not listed in this table. Brain lymphomas and malignant tumors of the pituitary and pineal glands are excluded.
Abbreviation used: SEER, Surveillance, Epidemiology, and End Results.
|
|